PJ Online | News (30 April 2005)

Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Salvadore
Vol 274 No 7347 p509-512
30 April 2005

This section
Reprint   Photocopy

PDF 230K, Acrobat Reader

News summary

DIARY   Branch meetings   Future Events   Conferences

509 New pharmaceutical care model schemes covering asthma and epilepsy announced for Scotland Two new pharmaceutical care model schemes (PCMS) are to be introduced in Scotland for asthma and epilepsy ...more

509 Essential small pharmacies scheme to end The Essential Small Pharmacies Scheme, which has for many years sustained predominantly rural pharmacies in England and Wales that would otherwise be unviable, is to come to an end ...more

509 Call to annotate Register for administrators The Royal Pharmaceutical Society’s Register of pharmacists should include a separate classification for administrative pharmacists, say members of the Association of Independent Multiple Pharmacies (AIMp) ...more

509 HRT increases womb cancer Postmenopausal women taking oestrogen-only hormone replacement therapy or tibolone have a greater risk of endometrial cancer than those taking combination HRT, say researchers. However, they note that since the risk of breast cancer is greater with combination HRT, total cancer incidence remains higher for combined HRT ...more

509 New chairman for NPA board Rajesh (Raj) Patel, a community pharmacist from Cheshire, has this week been elected chairman of the National Pharmaceutical Association for 2005–06 ...more

510 Election brings opportunities to promote pharmacy Key pharmacy bodies have been taking the opportunity to promote the profession during the run-up to the general election ...more

510 New health Bill in Scotland takes a step forwards Legislation required for the new community pharmacy contract in Scotland moved closer to reality last week when the Scottish Executive’s health committee announced its support for the Smoking, Health and Social Care (Scotland) Bill. The Bill will also result in strengthened disciplinary powers for the NHS over pharmacists who provide pharmaceutical care ...more

510 New contract worries for NPA The National Pharmaceutical Association is worried that pharmacy owners will be confused by a revised monthly reporting form that has been introduced with the new pharmacy contract ...more

510 Changes to generics reimbursement in Scotland Changes to the reimbursement of drugs in part 7 of the Scottish Drug Tariff were announced this week ...more

510 Increased fee for flu vaccine Community pharmacists in Scotland will be paid a two-tier professional fee for supplying influenza vaccines to GPs this year ...more

511 Evidence grows for pharmacist input in diabetes care Further evidence that pharmacists’ interventions improve glycaemic control in patients with type 2 diabetes was presented at the Diabetes UK annual professional conference in Glasgow last week ...more

511 EMEA completes review of SSRIs and recommends wider product warning Selective serotonin reuptake inhibitors and serotonin-norepinephrine reuptake inhibitors should not be used in children and adolescents except for their approved indications, the European Medicines Agency (EMEA) has concluded following its review of the antidepressants ...more

511 Booklets for patients with learning disabilities Three new booklets to help people with learning disabilities make informed decisions about their medicines were launched this week by Medicines Partnership and the Norah Fry Research Centre ...more

511 AAH new contract resource pack and CD-ROM launched AAH Pharmaceuticals has launched a resource pack to help its customers in England and Wales implement the new community pharmacy contract ...more

512 Modafinil fails to improve fatigue Modafinil, a drug used to treat daytime sleepiness, does not appear to improve fatigue in patients with multiple sclerosis, a trial has revealed. Aspirin, on the other hand, may reduce the severity of this symptom ...more

512 Calcium and vitamin D3 supplements do not prevent fractures Supplementation with calcium and vitamin D3, either alone or in combination, is not effective in the prevention of fractures in elderly people, according to two new UK studies ...more

512 Rosuvastatin reduces plaque size and changes composition Impact of rosuvastatin (Crestor) on the size and composition of atherosclerotic plaques in the carotid arteries has been shown by magnetic resonance imaging in the first trial of its kind. Data from the study were presented by AstraZeneca in London last week ...more

Back to Top

©The Salvadore

Citation: The Salvadore URI: 20014560

Rate this article 

Click to rate

  • 1 star out of 5
  • 2 stars out of 5
  • 3 stars out of 5
  • 4 stars out of 5
  • 5 stars out of 5

0 out of 5 stars

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

RPS publications

Pharmaceutical Press is the publishing division of the SalvaDore, and is a leading provider of authoritative pharmaceutical information used throughout the world.

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.

виагра цена в украине

варденафил цена